NCT05892172

Brief Summary

The purpose of this study is to analyze and summarize the characteristics of arrhythmia and heart rate variability of Chinese patients with three different types of heart failure combined with sleep disordered breathing based on the clinical data, to provide new diagnosis and treatment ideas for domestic patients, and then to improve the prognosis of patients betterly.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 18, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

June 7, 2023

Completed
21 days until next milestone

Study Start

First participant enrolled

June 28, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
Last Updated

June 29, 2023

Status Verified

May 1, 2023

Enrollment Period

6 months

First QC Date

May 18, 2023

Last Update Submit

June 28, 2023

Conditions

Keywords

sleep disordered breathingarrhythmiaheart rate variability

Outcome Measures

Primary Outcomes (1)

  • heart failure and sleep apnea

    analyze and summarize the characteristics of arrhythmia and heart rate variability of Chinese patients with three different types of heart failure combined with sleep-disordered breathing based on the clinical data. Collection of clinical data: general clinical data, physical signs, post-admission inspection indicators, and treatment conditions of patients collected from the electronic medical record system. Echocardiographic data mainly included ejection fraction, left atrial anterior-posterior diameter, and interventricular septum thickness, which were in millimeters; electrocardiogram examination mainly included Diagnosis type of arrhythmia by dynamic, the overall standard deviation of normal sinus R-R interval (SDNN), the average standard deviation of normal sinus R-R interval throughout the recording period (SDANN), which were in a millisecond, etc; The type and severity of sleep-disordered breathing and Apnea hypopnea index were obtained by polysomnography.

    24 hours

Study Arms (3)

HFrEF group

HFrEF was defined as Left ventricular ejection fraction ≤40%

HFmrEF group

HFmrEF was defined as Left ventricular ejection fraction 41%\~49%

HFpEF group

HFpEF was defined as Left ventricular ejection fraction ≥50%

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Heart failure patients hospitalized in the Department of Cardiology of the First Affiliated Hospital of Harbin Medical University

You may qualify if:

  • Age \>18 years.
  • The diagnosis of heart failure conforms to the criteria of the Chinese Guidelines for the Diagnosis and Treatment of Heart Failure .
  • Echocardiography, dynamic electrocardiogram and polysomnography monitoring should be improved during the period of hospitalization.
  • Patients with sleep apnea have not received standard treatment.

You may not qualify if:

  • Patients undergoing cardiac surgery in the past 6 weeks.
  • Patients with acute decompensated heart failure or heart failure requiring oxygen therapy.
  • All patients with sleep apnea who receive standard treatment.
  • Patients who use pacemakers or implantable cardioverter defibrillators.
  • The patient did not complete the echocardiography, dynamic electrocardiogram, and polysomnography monitoring during hospitalization.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yihui Kong

Harbin, Heilongjiang, 150000, China

RECRUITING

MeSH Terms

Conditions

Heart FailureSleep Apnea SyndromesArrhythmias, Cardiac

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Yihui Kong, M.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 18, 2023

First Posted

June 7, 2023

Study Start

June 28, 2023

Primary Completion

January 1, 2024

Study Completion

April 30, 2024

Last Updated

June 29, 2023

Record last verified: 2023-05

Locations